公开(公告)号：WO2015111002A1

公开(公告)日：2015-07-30

申请号：PCT/IB2015/050523

申请日：2015-01-23

Applicant: MEDISCA PHARMACEUTIQUE, INC.

Inventor： DUBOIS, Fanny ,  DANOPOULOS, Panagiota

IPC: A45D40/00 ,  A61K8/30 ,  A61K8/64 ,  A61K8/67 ,  A61K8/73 ,  A61K8/97 ,  A61Q19/00 ,  A61Q19/08

CPC classification number: A61K8/97 ,  A61K8/31 ,  A61K8/355 ,  A61K8/42 ,  A61K8/64 ,  A61K8/66 ,  A61K8/675 ,  A61K8/676 ,  A61K8/68 ,  A61K8/73 ,  A61K8/735 ,  A61K8/922 ,  A61K2800/87 ,  A61K2800/882 ,  A61Q19/005 ,  A61Q19/007 ,  A61Q19/008 ,  A61Q19/08 ,  G06Q30/0621 ,  G06Q99/00

Abstract: A kit (18) for preparing a customized cosmetic (11) includes at least one of five cosmetic bases (26, 28, 30, 32, 34). Each of the five cosmetic bases (26, 28, 30, 32, 34) corresponds to at least one of a plurality of primary categories (20a). The kit (18) additionally includes at least one cosmetic active ingredient (24) for admixing with the at least one cosmetic base (26, 28, 30, 32, 34). The at least one cosmetic active ingredient (24) corresponds to at least one of the plurality of primary categories (20a) or at least one of the plurality of secondary categories (20b).

Abstract translation: 用于制备定制化妆品（11）的试剂盒（18）包括五个化妆品基质（26,28,30,32,34）中的至少一个。 五个化妆品基座（26,28,30,32,34）中的每一个对应于多个主要类别（20a）中的至少一个。 试剂盒（18）还包括至少一种用于与至少一个化妆品基质（26,28,30,32,34）混合的化妆品活性成分（24）。 至少一种化妆品活性成分（24）对应于多个主要类别（20a）中的至少一个或多个次要类别（20b）中的至少一个。

公开(公告)号：WO2020232528A1

公开(公告)日：2020-11-26

申请号：PCT/CA2019/051783

申请日：2019-12-11

Applicant: MEDISCA PHARMACEUTIQUE INC.

Inventor： DANOPOULOS, Panagiota ,  DUBOIS, Fanny ,  CLARIDGE, Amanda

IPC: G16Z99/00 ,  A45D44/00 ,  A45D97/00 ,  G06Q30/06 ,  G16B99/00 ,  G16H20/10

Abstract: A computerized system for initiating preparation of a customized cosmeceutical formulation, comprising a processor configured to execute program instructions to instantiate a cosmeceutical utility configured for (i) obtaining a skin type, a first skin concern and a prioritized set of second skin concerns from a user; (ii) selecting a base composition from a set of base compositions based on the skin type and the first skin concern; (iii) selecting a subset of booster compositions by determining a prioritized original set of booster compositions based on the prioritized set of second skin concerns; and verifying mutual compatibility of a subset of booster compositions in the original set. If the verifying indicates incompatibility among two or more booster compositions in the subset, the utility is configured to substitute a lower-priority booster composition in the two or more booster compositions with a booster composition that is in the original set but not in the subset; and (iv) causing an electronic message comprising a request to be released towards a recipient, the request identifying the selected base composition and the selected subset of booster compositions.